Company profile: PBS Biotech
1.1 - Company Overview
Company description
- Provider of single-use Vertical-Wheel bioreactor systems and process development services for the cell therapy industry. Offers bioreactors across scales for process development and commercial manufacturing, including PBS-Mini (0.1–0.5 L), PBS-3 (3 L), PBS-15 (15 L), and PBS-80 (80 L), and services to develop scalable cell culture processes tailored to specific therapeutic cell types and manufacturing requirements.
Products and services
- PBS-80: Commercial-scale bioreactor with an 80 L working volume, engineered for manufacturing cell therapy products at production scale
- Process Development Services: Custom-engineered services that develop scalable cell culture processes tailored to specific therapeutic cell types and manufacturing requirements for the cell therapy industry
- Vertical-Wheel Bioreactors: Single-use bioreactor systems architected for cell therapy manufacturing, available in various sizes to support process development and commercial production stages
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PBS Biotech
Agilent
HQ: United States
Website
- Description: Provider of scientific and laboratory management solutions for analytical scientists and clinical researchers, offering instruments, software, and HPLC, GC & spectroscopy supplies for chemical analysis; life sciences tools for genomics, proteomics, and cell analysis; diagnostic solutions including pathology and molecular diagnostics; and products such as 8850 GC and NovoCyte Opteon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agilent company profile →
Xpand Biotech
HQ: The Netherlands
Website
- Description: Provider of bone repair and regeneration products based on proprietary surface science technology, with in-house R&D, manufacturing, and clean room facilities; based in Bilthoven, The Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xpand Biotech company profile →
Ziylo
HQ: United Kingdom
Website
- Description: Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ziylo company profile →
PreOmics
HQ: Germany
Website
- Description: Provider of innovative pre-analytics and sample preparation technologies for MS-based proteomics, supporting researchers in protein analysis. Offerings include iST kits for protein/peptide prep, TMT/iTRAQ-compatible chemical labeling (iST-NHS), minimized modifications in biofluids (iST-BCT), high-throughput positive-pressure prep (iST-PSI), peptide clean-up (iST Phoenix), and GFP IP enrichment (iST-Trap).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreOmics company profile →
PharmaFluidics
HQ: Belgium
Website
- Description: Provider of integrated milli- to nano-engineered solutions for mixing, separation and reaction processes, offering high-quality, tailor-made designs. Products include μPAC Neo silicon-based HPLC columns for high-resolution separations; EASY-Spray and Double nanoViper columns for nano/capillary LC-MS and robust proteomics; MAbPac RP for intact protein characterization; Accucore 150 Amide HILIC for hydrophilic biomolecules/glycans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaFluidics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PBS Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PBS Biotech
2.2 - Growth funds investing in similar companies to PBS Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PBS Biotech
4.2 - Public trading comparable groups for PBS Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →